Evidence map›Paper›PMID 32388516›Full record

ArticleMedicina oral, patologia oral y cirugia bucal2020

Comparative expression of cyclooxygenase 2 and Ki67 in amelanotic and conventional oral melanomas.

C-D Soares, J-C Hernandez-Guerrero, B-A Andrade, M-J Romañach, A Mosqueda-Taylor, R Carlos, M-R Macedo, O-P Almeida, J Jorge

Open access · diamondAbstract read
In one paragraph

Article in Medicina oral, patologia oral y cirugia bucal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Amelanotic Melanoma-Biochemical and Molecular Induction Pathways.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

C-D SoaresDepartment of Oral Diagnosis Piracicaba Dental School, University of Campinas Avenida Limeira, 901, Areião 13414-903 Piracicaba/SP, Brazil ciro.dss@gmail.com.
J-C Hernandez-Guerrero
B-A Andrade
M-J Romañach
A Mosqueda-Taylor
R Carlos
M-R Macedo
O-P Almeida
J Jorge
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal do Rio de Janeiro · BRCentro Universitario Ciudad Vieja · GTUniversidad Autónoma Metropolitana · MXUniversidade Federal do Rio Grande do Norte · BRUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral melanomas have some histopathological resemblance with its cutaneous counterpart; however, an aggressive behavior is more common in tumors that occur in the oral cavity. Several markers have been suggested as indicative of tumoral progression and aggressiveness, such as cyclooxygenase 2 (COX-2) and Ki67. MATERIAL AND

methodsIn this study, we have compared the expression of COX-2 and Ki67 in a series of amelanotic (n=7) and melanotic oral melanomas (n=22). The cases were selected from 4 pathology laboratories and submitted to the immunohistochemical (IHC) reactions. We analyzed the IHC staining based on a qualitative - using visual scores; and a computer-assisted method (quantitative) using scanned slides and software for digital analysis.

resultsCOX-2 was expressed in all oral melanomas; however, its intensity was significantly higher in the amelanotic ones (P<0.001). Similarly, a high Ki67-positivity index was observed in the amelanotic than melanotic ones (P<0.001).

conclusionsBased on these results, we suggest that amelanotic oral melanomas have marked pro-inflammatory and high-proliferative phenotype, justifying their more aggressive behavior compared with the melanotic ones.

Indexed as

Melanoma, AmelanoticMouth NeoplasmsSkin NeoplasmsCyclooxygenase 2HumansKi-67 AntigenCyclooxygenase 2Ki-67 Antigen

Identifiers

PMID32388516
PMCPMC7648925
OpenAlexW3020906766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.